NT5E and neoplasm: In patients with CD73-low tumours (CD73-positive expression in <50%), ORR was similar between the two arms: 58.3% [95% CI, 27.7–84.8] in the experimental arm and 60.0% [95% CI, 26.2–87.8] in the control arm (Supplementary Table S5).